Clinical Trial Update: Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether N-acetylcysteine affects cardiorespiratory control in patients with chronic obstructive pulmonary disease and mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Queen's University | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2018-06-14